Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

6,931

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

6,931 results for “Obesity.”

Learn how ShareScore rates datasets ↗
zenodo28/100

obese mouse walking

Drawing uploaded to scidraw.io on: 17 August 2019

opencc-by-4.0Jun 2020View details →
zenodo28/100

obese mouse eating

Drawing uploaded to scidraw.io on: 17 August 2019

opencc-by-4.0Jun 2020View details →
zenodo28/100

obese mouse lever

Drawing uploaded to scidraw.io on: 17 August 2019

opencc-by-4.0Jun 2020View details →
zenodo28/100

obese mouse rearing

Drawing uploaded to scidraw.io on: 17 August 2019

opencc-by-4.0Jun 2020View details →
dryad28/100

Data from: Curcumin improves glycolipid metabolism through regulating peroxisome proliferator activated receptor γ signalling pathway in high-fat diet-induced obese mice and 3T3-L1 adipocytes

Curcumin, an active component derived from the Curcuma longa L. which is a traditional Chinese medicine that is widely used for treating metabolic diseases through regulating different molecular pathway. Here, in this study, we aimed to comprehensively investigate the effects of curcumin on glycolipid metabolism in vivo and in vitro and then determine the underlying mechanism. Male C57BL/6J obese mice and 3T3-L1 adipocytes were used in vivo and in vitro study, respectively. Our results demonstrated that treatment with curcumin for 8 weeks decreased body weight, fat mass and serum lipid profiles. Meanwhile, it lowered fasting blood glucose and increased the insulin sensitivity in high-fat diet induced obese mice. In addition, curcumin stimulated lipolysis and improve glycolipid through upregulating the expressions of ATGL, HSL, PPARγ, C/EBPα and PPARα in adipose tissue of the mice. In differentiated 3T3-L1 cells, curcumin reduced glycerol release and increased glucose uptake via upregulating PPARγ and C/EBPα. We concluded that curcumin has potential to improve glycolipid metabolism disorders caused by obesity through regulating PPARγ signaling pathway.

opencc-zeroDec 2016View details →
dryad28/100

Data from: Maternal obesity increases insulin resistance, low-grade inflammation and osteochondrosis lesions in foals and yearlings until 18 months of age

Obesity is a growing concern in horses. The effects of maternal obesity on maternal metabolism and low-grade inflammation during pregnancy, as well as offspring growth, metabolism, low-grade inflammation, testicular maturation and osteochondrotic lesions until 18 months of age were investigated. Twenty-four mares were used and separated into two groups at insemination according to body condition score (BCS): Normal (N, n=10, BCS ≤4) and Obese (O, n=14, BCS ≥4.25). BCS and plasma glucose, insulin, triglyceride, urea, non-esterified fatty acid, serum amyloid A (SAA), leptin and adiponectin concentrations were monitored throughout gestation. At 300 days of gestation, a Frequently Sampled Intravenous Glucose Tolerance Test (FSIGT) was performed. After parturition, foals' weight and size were monitored until 18 months of age with plasma SAA, leptin, adiponectin, triiodothyronine (T3), thyroxine (T4) and cortisol concentrations measured at regular intervals. At 6, 12 and 18 months of age, FSIGT and osteoarticular examinations were performed. Males were gelded at one year and expression of genes involved in testicular maturation analysed by RT-qPCR. Throughout the experiment, maternal BCS was higher in O versus N mares. During gestation, plasma urea and adiponectin were decreased and SAA and leptin increased in O versus N mares. O mares were also more insulin resistant than N mares with a higher glucose effectiveness. Postnatally, there was no difference in offspring growth between groups. Nevertheless, SAA plasma concentrations were increased in O versus N foals until 6 months, with O foals being consistently more insulin resistant with a higher glucose effectiveness. At 12 months of age, O foals were significantly more affected by osteochondrosis than N foals. All other parameters were not different between groups. In conclusion, maternal obesity altered metabolism and increased low-grade inflammation in both dams and foals. The risk of developing osteochondrosis at 12 months of age was also higher in foals born to obese dams.

opencc-zeroDec 2017View details →
dryad28/100

Data from: Comparative analyses of QTLs influencing obesity and metabolic phenotypes in pigs and humans

The pig is a well-known animal model used to investigate genetic and mechanistic aspects of human disease biology. They are particularly useful in the context of obesity and metabolic diseases because other widely used models (e.g. mice) do not completely recapitulate key pathophysiological features associated with these diseases in humans. Therefore, we established a F2 pig resource population (n = 564) designed to elucidate the genetics underlying obesity and metabolic phenotypes. Segregation of obesity traits was ensured by using breeds highly divergent with respect to obesity traits in the parental generation. Several obesity and metabolic phenotypes were recorded (n = 35) from birth to slaughter (242 ± 48 days), including body composition determined at about two months of age (63 ± 10 days) via dual-energy x-ray absorptiometry (DXA) scanning. All pigs were genotyped using Illumina Porcine 60k SNP Beadchip and a combined linkage disequilibrium-linkage analysis was used to identify genome-wide significant associations for collected phenotypes. We identified 229 QTLs which associated with adiposity- and metabolic phenotypes at genome-wide significant levels. Subsequently comparative analyses were performed to identify the extent of overlap between previously identified QTLs in both humans and pigs. The combined analysis of a large number of obesity phenotypes has provided insight in the genetic architecture of the molecular mechanisms underlying these traits indicating that QTLs underlying similar phenotypes are clustered in the genome. Our analyses have further confirmed that genetic heterogeneity is an inherent characteristic of obesity traits most likely caused by segregation or fixation of different variants of the individual components belonging to cellular pathways in different populations. Several important genes previously associated to obesity in human studies, along with novel genes were identified. Altogether, this study provides novel insight that may further the current understanding of the molecular mechanisms underlying human obesity.

opencc-zeroDec 2014View details →
dryad28/100

Data from: Intestinal Ralstonia pickettii augments glucose intolerance in obesity

An altered intestinal microbiota composition has been implicated in the pathogenesis of metabolic disease including obesity and type 2 diabetes mellitus (T2DM). Low grade inflammation, potentially initiated by the intestinal microbiota, has been suggested to be a driving force in the development of insulin resistance in obesity. Here, we report that bacterial DNA is present in mesenteric adipose tissue of obese but otherwise healthy human subjects. Pyrosequencing of bacterial 16S rRNA genes revealed that DNA from the Gram-negative species Ralstonia was most prevalent. Interestingly, fecal abundance of Ralstonia pickettii was increased in obese subjects with pre-diabetes and T2DM. To assess if R. pickettii was causally involved in development of obesity and T2DM, we performed a proof-of-concept study in diet-induced obese (DIO) mice. Compared to vehicle-treated control mice, R. pickettii-treated DIO mice had reduced glucose tolerance. In addition, circulating levels of endotoxin were increased in R. pickettii-treated mice. In conclusion, this study suggests that intestinal Ralstonia is increased in obese human subjects with T2DM and reciprocally worsens glucose tolerance in DIO mice.

opencc-zeroDec 2016View details →
dryad28/100

Data from: Sympathetic nervous system activity and anti-lipolytic response to IV-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects

The study aim was to investigate the effect of endogenous insulin release on lipolysis in subcutaneous adipose tissue after adrenergic stimulation in obese subjects diagnosed with type 2 diabetes (T2D). In 14 obese female T2D subjects, or 14 obese non-T2D controls, glycerol concentration was measured in response to the α1,2,ß-agonist norepinephrine, the α1-agonist norfenefrine and the ß2-agonist terbutaline (each 10-4 M), using the microdialysis technique. After 60 minutes of stimulation, an intravenous glucose load (0.5 g/kg lean body mass) was given. Local blood flow was monitored by means of the ethanol technique. Norepinephrine and norfenefrine induced a four and three fold rise in glycerol dialysate concentration (p<0.001, each), with a similar pattern in adipose tissue. Following agonist stimulation and glucose infusion, endogenous insulin release inhibited lipolysis in the presence of norepinephrine, which was more rapid and pronounced in healthy obese controls than in T2D subjects (p=0.024 obese vs T2D subjects). Insulin-induced inhibition of lipolysis in the presence of norfenefrine was similar in all study participants. In the presence of terbutaline the lipolysis rate increased two fold until the effect of endogenous insulin (p<0.001). A similar insulin-induced decrease in lipolysis was observed for each of the norfenefrine groups and the terbutaline groups, respectively. Adipose tissue blood flow remained unchanged after the iv-glucose load. Both norepinephrine and norfenefrine diminished blood flow slightly, but insulin reversed this response (p<0.001 over the entire time). Terbutaline alone and terbutaline plus increased endogenous insulin augmented local blood flow (p<0.001 over the entire time). In conclusion, a difference in insulin-induced inhibition of lipolysis was observed in obese T2D subjects compared to obese healthy controls following modulation of sympathetic nervous system activity and is assumed to be due to ß1-adrenoceptor mediated stimulation by norepinephrine.

opencc-zeroDec 2016View details →
zenodo28/100

Figure 3 from: Musfiroh I, Megawati G, Diah Herawati DM, Nama Putra O, Sylvia Nurrasjid E (2023) Molecular dynamic of omega-3 compounds as an anti-obesity agent into GPR-120 receptor. Pharmacia 70(4): 1541-1548. https://doi.org/10.3897/pharmacia.70.e115501

Figure 3 A. Visualization of interactions between docosahexaenoic acid and receptors (GPR120 (4GRV)) and B. Visualization of molecular docking between the receptor GPR120 (4GRV) and docosahexaenoic acid.

opencc-by-4.0Dec 2023View details →
zenodo28/100

Figure 2 from: Musfiroh I, Megawati G, Diah Herawati DM, Nama Putra O, Sylvia Nurrasjid E (2023) Molecular dynamic of omega-3 compounds as an anti-obesity agent into GPR-120 receptor. Pharmacia 70(4): 1541-1548. https://doi.org/10.3897/pharmacia.70.e115501

Figure 2 A. Visualization of interactions between Neurotensin 8–13 and receptors (4GRV) and B. Visualization of molecular docking between the receptor 4GRV and natural ligand.

opencc-by-4.0Dec 2023View details →
zenodo28/100

Figure 1 from: Musfiroh I, Megawati G, Diah Herawati DM, Nama Putra O, Sylvia Nurrasjid E (2023) Molecular dynamic of omega-3 compounds as an anti-obesity agent into GPR-120 receptor. Pharmacia 70(4): 1541-1548. https://doi.org/10.3897/pharmacia.70.e115501

Figure 1 A. Neurotensin receptor (4GRV) and B. Overlay of the docked pose of Neurotensin 8–13 with the co-crystallized ligand 4GRV.

opencc-by-4.0Dec 2023View details →
zenodo28/100

Figure 4 from: Musfiroh I, Megawati G, Diah Herawati DM, Nama Putra O, Sylvia Nurrasjid E (2023) Molecular dynamic of omega-3 compounds as an anti-obesity agent into GPR-120 receptor. Pharmacia 70(4): 1541-1548. https://doi.org/10.3897/pharmacia.70.e115501

Figure 4 RMSD (a) and RMSF (b) value of docosahexaenoic acid (blue), eicosapentaenoic acid (maroon), and heneicosapentaenoic acid (green).

opencc-by-4.0Dec 2023View details →
zenodo28/100

Figure 5 from: Musfiroh I, Megawati G, Diah Herawati DM, Nama Putra O, Sylvia Nurrasjid E (2023) Molecular dynamic of omega-3 compounds as an anti-obesity agent into GPR-120 receptor. Pharmacia 70(4): 1541-1548. https://doi.org/10.3897/pharmacia.70.e115501

Figure 5 SASA plot of docosahexaenoic acid (blue), eicosapentaenoic acid (maroon), and heneicosapentaenoic acid (green).

opencc-by-4.0Dec 2023View details →
zenodo28/100

Association between the triglyceride glucose index and short-term mortality in septic patients with or without obesity

Open the record for dataset details and reuse information.

opencc-by-4.0Mar 2024View details →
zenodo28/100

Marketing to reduce Chilhood Obesity

<p>Ponencia - IV Congreso Latinoamericano de Marketing Social</p>

opencc-by-4.0Oct 2022View details →
zenodo28/100

Review of Breast Cancer Prognosis MicroRNAslncRNAs, Obesity, The LPR6 Biomarker, and Night Fasting

Open the record for dataset details and reuse information.

opencc-by-4.0Mar 2024View details →
zenodo28/100

Effect of a modified 5:2 intermittent fasting diet on population with overweight or obesity in China: A self-controlled clinical trial

Open the record for dataset details and reuse information.

opencc-by-4.0Nov 2024View details →
zenodo28/100

Adherence to the Mediterranean diet and risk of anxiety and depression in people with obesity: a cross-sectional analysis

Open the record for dataset details and reuse information.

opencc-by-4.0Nov 2024View details →
zenodo28/100

Influence of Mediterranean Foods on Gut Microbiota Functionality in Obese Children Compared to Lean Children (Supplemental information)

<p>Complete dataset including the antioxidant capacity for all foods tested with 3 antioxidant method.</p>

opencc-by-4.0Feb 2022View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.